Risk of Myocarditis and Pericarditis With Bivalent RSV Prefusion F Protein-Based Vaccine: A Safety Analysis of the Extended DAN-RSV Trial

Scritto il 29/08/2026
da Marat Yafasov

No abstract

J Am Coll Cardiol. 2026 Aug 29:S0735-1097(26)07510-8. doi: 10.1016/j.jacc.2026.08.027. Online ahead of print.

NO ABSTRACT

PMID:42667277 | DOI:10.1016/j.jacc.2026.08.027